DG
About
Doug serves as President at Regado Biosciences, one of Aurora’s portfolio companies. As a Venture Partner for Aurora, he works primarily with Aurora's life science portfolio, specifically in the areas of biotechnology, drug discovery and development. Doug serves on the Board of Directors of Metabolon and Cropsolution. Prior to joining Aurora in 2001, he was a Director of Business Development at Paradigm Genetics (PDGM). Doug also spent four years at Incyte Pharmaceuticals (INCY), where he was the manager of the cDNA Library Construction Group. In addition, he worked as a Research Associate at Stratagene Cloning Systems in La Jolla, California.
Position in the VCSift Database
- • 4 investors at The Aurora Funds are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Doug Gooding is one of them.
- • 982 investors are based in Atlanta, Georgia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Atlanta, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Doug
Search Investors